Skip to main content

Krystal Biotech, Inc.

KRYS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001711279

In the last 90 days, Krystal Biotech, Inc. insiders filed 0 open-market purchases and 3 sales; 422 institutions reported holding it in 13F filings for Q2 2026, worth $11.1B in total; no superinvestor holds it.

Politicians who traded KRYS

Since 2020, newest trade first. Shares and options by default, including trades reported under an earlier ticker.

Trades
1
Filings
1
Politicians
1
Buys / sells
1 / 0
Estimated volume
$8.00K
Sum of range midpoints
Politicians who traded KRYS
PoliticianTradesBuys / sellsEst. volumeLast tradedLast filed
Chris Jacobs House · NY
11 / 0$8.00KDec 12, 2022Jan 20, 2023

Trades

Reported trades in Krystal Biotech, Inc., newest filings first.

Politician trades
PoliticianAssetTypeOwnerTradedFiledDelayAmountSource
Chris Jacobs House · NY
KRYSKrystal Biotech, Inc.BuySelfDec 12, 2022Jan 20, 202339 days$1K-$15KFiling

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report. Profiles, committees and photos: the unitedstates project (public domain). District maps: U.S. Census Bureau.